Multivalve disease: defining pathways for optimal assessment and treatment in the absence of good clinical evidence

Partners in Learning - a PCR/CRF Collaboration

Spokesperson: A. Asgar

Discussants: M. Garbi, J. Hausleiter, R. Makkar, T. Patterson, G. Tang

Summary

Curious about managing multivalve disease in the absence of robust clinical evidence? This video is a must-watch!

You'll explore the latest strategies for assessing and treating this condition (including advanced multimodality investigations like echocardiography, magnetic resonance and cardiac catheterisation), and learn how to evaluate cardiopulmonary interactions and how to identify high-risk patients to ensure best clinical outcomes.

Learning Objectives

To appreciate the frequency of multivalve disease and its association with poor clinical outcomes
To understand the need for comprehensive multimodality investigation, including assessment of the pulmonary circulation and right ventricular function
To learn how to identify high risk patients and instigate measures that will ensure best clinical outcomes

Presentations available when logged in:

Welcome and session objectives
Modern means of multi-modality assessment: advanced echocardiography, magnetic resonance or cardiac catheterisation?
Cardiopulmonary interaction: the impact of the pulmonary circulation and right ventricular function
High risk combinations: measures for haemodynamic support and the role of procedural sequencing

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Multivalve disease: defining pathways for optimal assessment and treatment in the absence of good clinical evidence

Partners in Learning - a PCR/CRF Collaboration

Learning Objectives

Log in or create account for free